Neuronetics, Inc.
13.92%
10,602,988
1227636
Aug 13, 2026
Aug 24, 2026, 08:03 PM
Reporting Persons (1)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Chernett Jorey | Individual | 13.92% | 10,602,988 | 10,602,988 | 0 |
Disclosure Items (3)
Common Stock, $0.01 par value
Neuronetics, Inc.
3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355
Item 3 is hereby amended and restated as follows: The 10,602,988 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,726,476.
Item 5(a) is hereby amended and restated as follows: The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 76,197,222 Shares outstanding as of August 5, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on August 11, 2026. As of the close of business on the date hereof, the Reporting Person beneficially owned 10,602,988 Shares. Percentage: Approximately 13.92%
Item 5(b) is hereby amended and restated as follows: 1. Sole power to vote or direct vote: 10,602,988 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 10,602,988 4. Shared power to dispose or direct the disposition: 0
Item 5(c) is hereby amended and restated as follows: The transactions in the Shares by the Reporting Person since the filing of Amendment No. 3 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.